BRAINTEASER is excited to take part in the iDPP@CLEF Challenge 2022 happening on 5-8 September, We recently spoke about the event with organiser and full-time computer science professor Nicola Ferro …
The first out of four BRAINTEASER Focus Groups dedicated to the project’s results exploitation and sustainability, was held on February 1st 2022. These exploitation Focus Groups aim to broaden the …
The inherent complexity of degenerative neurological diseases, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), and the particular requirement for unravelling new biomarkers warrant a novel approach that …
The Intelligent Disease Progression Prediction (iDPP) challenge aims at designing and developing an evaluation infrastructure for AI algorithms able to: ● better describe disease mechanisms; ● stratify patients …
On the 24th of November 2021, The Digital Health Society (DHS) and the ECHAlliance hosted a panel session within the Digital Health Society Summit 2021, on “Cultural and regional aspects …
The use of technologies in the treatment and management of multiple sclerosis: the experience of Pieter van Galen, Patient advocate, European Multiple Sclerosis Platform (EMSP) Pieter van Galen is from …
On the 24th of November 2021, The Digital Health Society (DHS) and the ECHAlliance hosted a panel session within the Digital Health Society Summit 2021, on “Cultural and regional aspects …
Started on January 2021, the 4 years Horizon 2020 BRAINTEASER project seeks to exploit the value of artificial intelligence, big data—including those related to health, lifestyle habits and environment—, low-cost …